ENMD-2076 is an orally active kinase inhibitor with antiangiogenic and antiproliferative mechanisms of action by Fletcher, Graham C, Brokx, Richard D, Denny, Trisha A, Hembrough, Todd A, Plum, Stacy M, Fogler, William E, Sidor, Carolyn F, Bray, Mark R

Get full text

Cytokine-mediated FOXO3a phosphorylation suppresses FasL expression in hemopoietic cell lines: Investigations of the role of Fas in apoptosis due to cytokine starvation by Behzad, Hayedeh, Jamil, Sarwat, Denny, Trisha A., Duronio, Vincent

Get full text

Abstract P6-10-13: An update to a Phase I trial of CFI-402257, an oral TTK inhibitor, in patients with advanced solid tumors with HER2-negative breast cancer expansion cohorts by Hilton, John, Renouf, Daniel, Cescon, David W., Hansen, Aaron, Razak, Alibiruni Abdul, Stayner, Lee-Anne, Denny, Trisha A., Roberts-Thomson, Emily, Chen, Dih-Yih, Bray, Mark, Bedard, Philippe

Get full text

MKC-1 Is a Novel Agent That Induces Cell Cycle Arrest and Disrupts Multiple Survival Pathways in Hematologic Cancers by Denny, Trisha A., Chen, Xiaoru, Waters, Cassandra L., Burke, Patricia A., Fletcher, Graham C., Xu, John, Sidor, Carolyn F., Minden, Mark D., LaVallee, Theresa M., Bray, Mark R.

Get full text

ENMD-981693 Is an Orally-Active Kinase Inhibitor with Activity towards Human Hematologic Cancers In Vitro and In Vivo by Bray, Mark R., Fletcher, Graham C., Denny, Trisha A., Xu, John, Chen, Xiaoru, Burke, Patricia A., Franklin, Wanda, LaVallee, Theresa M., Minden, Mark D., Sidor, Carolyn F.

Get full text

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial by Veitch, Zachary W., Cescon, David W., Denny, Trisha, Yonemoto, Lisa-Maria, Fletcher, Graham, Brokx, Richard, Sampson, Peter, Li, Sze-Wan, Pugh, Trevor J., Bruce, Jeffrey, Bray, Mark R., Slamon, Dennis J., Mak, Tak W., Wainberg, Zev A., Bedard, Philippe L.

Get full text

Physical activity virtual intervention for improving mental health among university students during the COVID-19 pandemic: A Co-creation process and evaluation using the Behavior C... by Sofro, Zaenal Muttaqien, Wibowo, Rakhmat Ari, Wasityastuti, Widya, Kusumadewi, Andrian Fajar, Utomo, Prattama Santoso, Ekawati, Fitriana Murriya, Putri, Rayhani Erika, Aldrin, Enrique, Fatmawati, Jihan Santika, Chang, Trisha Cheeren, Pratista, Muhammad Ivan, Agustiningsih, Denny

Get full text

Abstract P1-18-17: Phase I study of cfi-402257, an oral ttk inhibitor, in patients with advanced solid tumors with breast cancer expansion cohorts by Hilton, John, Renouf, Daniel J, Cescon, David W, Hansen, Aaron R, Razak, Albiruni RA, Stayner, Lee-Anne, Denny, Trisha, Fletcher, Graham, Mak, Tak W, Bray, Mark, Bedard, Philippe L

Get full text

Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors by Anandan, Sampath-Kumar, Ward, John S., Brokx, Richard D., Denny, Trisha, Bray, Mark R., Patel, Dinesh V., Xiao, Xiao-Yi

Get full text